Regarding Severe-Death hematologic cancer patients, we observed a chemokine axis involving CCL2, CCL3, CXCL8 and IL-6, and an inverse correlation between IL-1β and monocytes (Figure 7C), indicating that those patients displayed an exacerbated inflammatory response as compared to patients that recovered from COVID-19. This evidence concerns the gene CCL2 and COVID-19.